Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When it comes to the two weight-loss drug options, Musk shared his personal takes on both.
IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight loss
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, whether they utilize weight loss drugs or not,” IBX said in a statement.
What to Know About Ozempic, Wegovy and the New Weight-Loss Market
Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new class of weight-loss drugs.
Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of himself wearing a Santa costume. "Ozempic Santa," the Tesla and SpaceX CEO posted alongside a photo of himself in the classic red outfit and white beard.
Elon Musk just got the best Christmas gift he could ask for
Elon Musk has a lot going on as 2024 winds to a close. The CEO of both Tesla (TSLA) and SpaceX is finishing a busy year that brought plenty of updates from both companies. 💰💸 Don’t miss the move: SIGN UP for TheStreet’s FREE Daily newsletter 💰💸 Now,
Elon Musk dubs himself "Ozempic Santa" as weight loss drugs go mainstream
Elon Musk showed off a trimmer figure in a holiday social media post on Wednesday while revealing that he has been taking an anti-obesity drug to shed pounds. Why it matters: Musk's post highlighted just how mainstream weight-loss drugs like Ozempic and Wegovy have become in recent years as public figures openly admit to using them,
Elon Musk Calls Himself 'Ozempic Santa' In Festive New Photo
A noticeably slimmed-down Elon Musk joked about his weight loss after he was photographed dressed up as Old Saint Nick.
A Slimmer Elon Musk Poses as ‘Ozempic Santa’ in Bizarre Snap
Billionaire Tesla CEO Elon Musk showed off a slimmer build in a Christmas day tweet in which he declared himself, “Ozempic Santa.” In the photo shared with the tweet, Musk strikes a modelesque pose in front of a Christmas tree while dressed as Santa Claus.
7h
on MSN
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using a Compounding Pharmacy
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
9h
on MSN
Elon Musk's 'Ozempic Santa' post turns heads, clashes with RFK Jr.'s stance
On Christmas Day, Elon Musk turned heads with a decadent photo by his tree. Dressed head-to-toe in a Santa costume, he ...
The Motley Fool on MSN
14h
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
Novo's Ozempic is approved by the U.S. Food and Drug Administration (FDA) to treat diabetes, while
Wegovy
is primarily ...
13h
Will Novo Nordisk (NVO) Stock Recover To $145 Levels?
Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...
13d
on MSN
For people who couldn’t get Ozempic or Wegovy, 2025 could be your year (if you can afford it)
It’s quickly become evident that GLP-1 drugs for diabetes, weight loss, and more are the new wonder drugs—if only people ...
BizPac Review
17h
Elon Musk jokes about being ‘Ozempic Santa’ with trimmed-down selfie
DOGE co-chair Elon Musk shocked his followers on Christmas Day by posting a tweet of his trimmed-down self in a Santa outfit.
24/7 Wall St
14h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
dailymemphian
3d
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
Opinion
2d
Opinion
We've Accepted Wegovy and Zepbound. The Next Phase Is Harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
weight loss
Mounjaro
drugs
Elon Musk
Feedback